ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
66,766.95
-0.26%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Medincell SA (MEDCL) Quote

Medincell SA

Medincell SA (MEDCL)

EU
14.20
0.50
(3.65%)
Closed May 19 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
14.20
Bid
14.02
Ask
14.28
Volume
119,450
13.54 Day's Range 14.20
5.25 52 Week Range 17.50
Market Cap
412.806M
Previous Close
13.70
Open
13.54
Last Trade
124
@
14.2
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
103,860
Shares Outstanding
29,070,871
Dividend Yield
-
PE Ratio
-12.90
Earnings Per Share (EPS)
-1.1
Revenue
14.38M
Net Profit
-32.01M

About Medincell SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.medincell.com
Headquarters
Jacou, Occitan, Fra
Founded
1970
Medincell SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MEDCL. The last closing price for Medincell was 13.70 €. Over the last year, Medincell shares have traded in a share price range of 5.25 € to 17.50 €.

Medincell currently has 29,070,871 shares outstanding. The market capitalization of Medincell is 412.81 € million. Medincell has a price to earnings ratio (PE ratio) of -12.90.

MEDCL Latest News

More News

Medincell fait le point sur l’essai clinique de phase 3 de mdc-CWM

Medincell tiendra une vidéoconférence le 15 mai 2024 à 10h30 CEST pour commenter les dernières actualités, les perspectives et les activités R&D de la société Pour participer à la conférence...

May 14 2024
Business Wire

Medincell tiendra une vidéoconférence le mercredi 15 mai 2024 à 10h30 pour commenter ses actualités récentes, ses perspectives et ses activités R&D

Pour participer à la conférence, inscrivez-vous en cliquant ici Regulatory News: Medincell (Paris:MEDCL) est une société de licensing biopharmaceutique en phase clinique et commerciale qui...

May 13 2024
Business Wire

Medincell : Information mensuelle relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: Medincell (Paris:MEDCL) : Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605...

May 10 2024
Business Wire

Teva et Medincell annoncent des résultats d'efficacité positifs pour l’essai de phase 3 SOLARIS de TEV-‘749 (olanzapine / mdc-TJK), injection sous-cutanée à action prolongée mensuelle pour les adultes atteints de schizophrénie

L'étude a atteint son critère d’évaluation principal dans tous les groupes ayant reçu des doses de TV-‘749 comparés au groupe placebo, en obtenant des réductions remarquables d’un point de vue...

May 08 2024
Business Wire

Medincell announces the suspension of listing of its shares on Euronext Paris

Regulatory News: The listing of the Medincell (Paris:MEDCL) shares on Euronext Paris has been suspended at the request of the Company, pending the publication of a press release. Trading on...

May 08 2024
Business Wire

Medincell présentera l’accord stratégique de co-développement et de licence avec AbbVie à l’occasion d’un webinaire le 17 avril à 10h00 CEST

Regulatory News: Stratégie, cadre de la collaboration, termes financiers de l’accord, perspectives pour Medincell (Paris:MEDCL) : le management vous invite à un webinaire de présentation de...

April 16 2024
Business Wire

Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies

Medincell will receive an upfront payment of $35 million and is eligible for up to $1.9 billion in potential development and commercial milestones, plus royalties on worldwide sales. Medincell...

April 16 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.2-7.7922077922115.415.6613.4223189814.51918402DE
43.229.09090909091117.510.7618371313.96212409DE
125.257.7777777778917.58.6810386012.29133319DE
268.12133.5526315796.0817.55.927838710.45973642DE
527.17101.9914651497.0317.55.25632938.87768352DE
1564.0640.039447731810.1417.54.73420028.39835709DE
2607.26104.6109510096.94204.35389569.30377015DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DUOFangDD Network Group Ltd
$ 1.65
(313.74%)
104.68M
FLJFLJ Group Limited
$ 1.54
(220.90%)
57.28M
JFBRJeffs Brands Ltd
$ 0.6276
(102.45%)
37.97M
IPWiPower Inc
$ 2.89
(97.95%)
11.05M
CETXCemtrex Inc
$ 0.4851
(48.58%)
21.23M
BSFCBlue Star Foods Corporation
$ 0.0757
(-45.26%)
60.09M
SINTSiNtx Technologies Inc
$ 0.084602
(-39.57%)
156.35M
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
HSCSHeart Test Laboratories Inc
$ 7.00
(-38.11%)
348.9k
AMPGAmplitech Group Inc
$ 1.46
(-32.09%)
613.31k
CRKNCrown Electrokinetics Corporation
$ 0.171
(-28.75%)
1.74B
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
GWAVGreenwave Technology Solutions Inc
$ 0.1541
(4.05%)
1.16B
AKANAkanda Corporation
$ 0.1726
(30.26%)
566.51M
PEGYPineapple Energy Inc
$ 0.1053
(-28.85%)
219.25M

Discussion

View Full Feed
WALLnut WALLnut 29 seconds ago
It appears they're done selling. OTC update showing no additional shared sold Friday. Before the 11m sell, os was at 388m.




RDGL
RDGL
Eagle1 Eagle1 42 seconds ago
Ok Fair Enough.
GDVM
pos_stock_hoarder pos_stock_hoarder 59 seconds ago
Wow. That IS impressive!
pos_stock_hoarder pos_stock_hoarder 2 minutes ago
They will not let the debates happen. Trump will have a mandatory court date for not watering one of his plants back in 1988. Or something equally pressing made up by the left.
MirageUnicorn76 MirageUnicorn76 3 minutes ago
Has anyone noticed that K2 Principal Fund LP, and its manager Adrian Morante, haven't posted any PR that they are named in a $140M lawsuit claiming insider trading?
What will that lawsuit mean for the K2 Principal Fund?
See: https://www.verticalfarmdaily.com/article/9591808/theracan
AVXL
stockwatcher1970 stockwatcher1970 3 minutes ago
What’s the significance of this?
CRTG
MirageUnicorn76 MirageUnicorn76 4 minutes ago
Has anyone noticed that K2 Principal Fund LP, and its manager Adrian Morante, haven't posted any PR that they are named in a $140M lawsuit claiming insider trading? (
What will that lawsuit mean for the K2 Principal Fund?
See: https://www.verticalfarmdaily.com/article/9591808/theraca
IGPK
Zorax Zorax 5 minutes ago
Thanks, newmedman cleared that up as well. The reason why I can never seem to solve it myself is none of these social sites now allow a non account to go past the very first link. Since mush took over, he took away viewing replies completely. Used to be able to go a few pages in and see some respons
Ecomike Ecomike 5 minutes ago
NNVC is just Phase one, and has years of work ahead of them, while Bixt, Bioxytran has 2 phase III trials ready in the USA and India, and they have shown a 100% cure rate (unheard of) in a week or less, with no Paxlovid rebound. It is an oral pill, a Galectin-3 Antagonist, that blocks the viruses fr
NNVC
pos_stock_hoarder pos_stock_hoarder 5 minutes ago
Diner time!

https://assets.amuniversal.com/5b03e980d9a1013c4a54005056a9545d
MirageUnicorn76 MirageUnicorn76 5 minutes ago
Has anyone noticed that K2 Principal Fund LP, and its manager Adrian Morante, haven't posted any PR that they are named in a $140M lawsuit claiming insider trading?
What will that lawsuit mean for the K2 Principal Fund?
See: https://www.verticalfarmdaily.com/article/9591808/theracann
DBMM
kfox kfox 5 minutes ago
Stick to the stock. Your opinion on politics is not shared by me and a number of others.. but as common shareholders our views on this stock are of interest to all.
RONN
pos_stock_hoarder pos_stock_hoarder 6 minutes ago
Bon Appetite as well for afterwards!

https://assets.amuniversal.com/5b03e980d9a1013c4a54005056a9545d
Zardiw Zardiw 7 minutes ago
Yeah....lol.....Closing the Barn door after all the Arabian horses are roaming the cuntryside........lol

Z
nshi2 nshi2 7 minutes ago
https://currently.att.yahoo.com/finance/m/06548163-83f0-3b33-9f3e-8d8a0eeabee4/bitcoin-institutional-etf.html

https://currently.att.yahoo.com/finance/news/banks-hedge-funds-pensions-buying-201500262.html
NSAV
Biowatch Biowatch 7 minutes ago
FDA approves self-tests for cervical cancer, as an alternative to the dreaded pelvic exam

[Dreaded pelvic exam?? Could save your life, or it’s an attention grabbing headline, or healthcare companies won’t pay for it…]
https://www.msn.com/en-us/health/other/fda-approves-self-tes
Vexari Vexari 7 minutes ago
4, 54, 48 @5:30
DiscoverGold DiscoverGold 8 minutes ago
Copper's rally is hinting that the inflation story isn't quite over yet . . .
By: Markets & Mayhem | May 18, 2024

• Copper's rally is hinting that the inflation story isn't quite over yet . . .

pbs.twimg.com/media/GN3XrtZWUAAzyWY?format=png&name=large
MirageUnicorn76 MirageUnicorn76 8 minutes ago
Has anyone noticed that K2 Principal Fund LP, and its manager Adrian Morante, haven't posted any PR that they are named in a $140M lawsuit claiming insider trading? (
What will that lawsuit mean for the K2 Principal Fund?
See: https://www.verticalfarmdaily.com/article/9591808/theracan
NSAV
eyeownu eyeownu 8 minutes ago
https://i.ibb.co/HNb74hW/image.png
Shares Outstanding 41.75M
Implied Shares Outstanding 51.75M
Float 1.73M%
Held by Insiders 57.79%%
Held by Institutions 0.49%
Shares Short (4/30/2024) 748.61k
Short Ratio (4/30/2024) 0.24Short % of Float (4/30/2
GDHG
Denzel-72 Denzel-72 9 minutes ago
Where does it say that ?
KEGS
Rodney5 Rodney5 9 minutes ago
As you said, “if you look at it from 2007 is unfair, involved accounting fraud and government deception” …

why not be a good citizen write about it publish it on your seeking alpha? Explain to us what’s unfair, accounting fraud, government deception. If seeking alpha want let you pub
FNMA
DiscoverGold DiscoverGold 10 minutes ago
Orange juice continues to make new all-time highs after its breakout, and there's likely room higher from here as long positioning is pretty low vs the last run with momentum traders adding to modest positions
By: Markets & Mayhem | May 19, 2024

• Orange juice continues t
Zorax Zorax 10 minutes ago
Page is missing.

Your Recent History

EU
MEDCL
Medincell
ASX
ALU
Altium
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved